AstraZeneca PLC is 169.7x more valuable than Generate Biomedicines, Inc. by market capitalization ($286.27 B vs $1.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GENB | AZN |
|---|---|---|
| Market cap | $1.69 B | $286.27 B |
| US-listed rank | #2227 | #45 |
| SEC filings | 47 | 1,004 |
AstraZeneca PLC is 169.7x more valuable than Generate Biomedicines, Inc. by market capitalization ($286.27 B vs $1.69 B).
Full pages: Generate Biomedicines, Inc. and AstraZeneca PLC, or browse the full rankings.